Khalid Islam's Net Worth
$785 Thousand
Who is Khalid Islam?
Khalid Islam does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, FENNEC PHARMACEUTICALS INC., Gain Therapeutics, Inc., and Processa Pharmaceuticals, Inc..
SEC CIK
Khalid Islam's CIK is 0001701858
Past Insider Trading and Trends
2023 was Khalid Islam's most active year for acquiring shares with 6 total transactions. Khalid Islam's most active month to acquire stocks was the month of May. 2023 was Khalid Islam's most active year for disposing of shares, totalling 4 transactions. Khalid Islam's most active month to dispose stocks was the month of October. 2023 saw Khalid Islam paying a total of $441,399.71 for 249,325 shares, this is the most they've acquired in one year. In 2023 Khalid Islam cashed out on 213,825 shares for a total of $441,399.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNOMEDICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.52K |
—
|
—
|
0
|
Oct 23
| |||
Form 4
| +27.51% | 3.72K |
—
|
—
| 17.23K |
Jun 18
| |||
Form 4
| +251.16% | 9.67K |
—
|
—
| 13.52K |
Jun 7
| |||
Form 4
|
∞
| 3.85K |
—
|
—
| 3.85K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FENNEC PHARMACEUTICALS INC. (FENC) Snapshot price: $5.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
∞
| 213.82K |
$2.06 | $441,399.71 | 213.82K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gain Therapeutics, Inc. (GANX) Snapshot price: $1
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 50K |
$1.00 | $49,940.00 | 50K |
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Processa Pharmaceuticals, Inc. (PCSA) Snapshot price: $1.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
| +6.45% | 4.39K |
—
|
—
| 72.49K |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||